Nanotrain For Targeted Cancer Drug Transport

University of Florida researchers have developed a “DNA nanotrain” that fast-tracks its payload of cancer-fighting drugs and bioimaging agents to tumor cells deep within the body. The nanotrain’s ability to cost-effectively deliver high doses of drugs to precisely targeted cancers and other medical maladies without leaving behind toxic nano-clutter has been the elusive Holy Grail for scientists studying the teeny-tiny world of DNA nanotechnology.
nano_train-nanochain

Most nanotechnology relies on a nanoparticle approach, and the particles are made of inorganic materials; after they’ve been used as a carrier for the drug, they’ll be left inside the body,” said the study’s lead investigator, Weihong Tan, a UF distinguished professor of chemistry, professor of physiology and functional genomics, and a member of the UF Shands Cancer Center and the UF Genetics Institute. “Compared to existing nanostructures, our nanotrain is easier and cheaper to make, is highly specific to cancer cells, has a lot of drug-loading power and is very much biocompatible.

DNA nanotechnology holds great promise as a new way to deliver chemotherapy directly to cancer cells, but until now, scientists have not been able to direct nanotherapies to consistently differentiate cancer cells from healthy ones. Other limiting factors include high costs, too-small amounts of drugs delivered and potential toxic side effects.
Source: http://news.ufl.edu/

Nanorobots To Kill Cancer

University of Florida researchers have moved a step closer to treating diseases on a cellular level by creating a tiny particle that can be programmed to shut down the genetic production line that cranks out disease-related proteins. In laboratory tests, these newly created “nanorobots” all but eradicated hepatitis C virus infection. The programmable nature of the particle makes it potentially useful against diseases such as cancer and other viral infections.

This is a novel technology that may have broad application because it can target essentially any gene we want,” said Dr. Chen Liu, professor of pathology at the University of Florida. “This opens the door to new fields so we can test many other things. We’re excited about it.

A team from MIT is working in the same direction:
See NanoComputer.com former articles:
http://www.nanocomputer.com/?p=2722
AND

http://www.nanocomputer.com/?p=2883

Source:  http://news.ufl.edu/2012/07/16/nanobot/

Record for graphene solar cell efficiency

Graphene solar cells are one of industry's great hopes for cheaper, durable solar power cells in the future. But previous attempts to use graphene, a single-atom-thick honeycomb lattice of carbon atoms, in solar cells have only managed power conversion efficiencies ranging up to 2.9 percent. A team from the University of Florida (UF) was able to achieve a record breaking 8.6 percent efficiency with their device by chemically treating, or doping, the graphene with trifluoromethanesulfonyl-amide, or TFSA. Their results are published in the current online edition of Nano Letters.

"The dopant makes the graphene film more conductive and increases the electric field potential inside the cell," said Xiaochang Miao, a graduate student in the physics department. That makes it more efficient at converting sunlight into electricity. And unlike other dopants that have been tried in the past, TFSA is stable — its effects are long lasting.

source: http://news.ufl.edu/2012/05/24/solar-efficiency/